Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella Typhimurium O-polysaccharide is the highly immunogenic, outermost component of the lipopolysaccharide (LPS) found on the cell surface of Salmonella enterica serovar Typhimurium. It consists of repeating oligosaccharide units—typically comprising D-galactose, L-rhamnose, and D-mannose with an abequose side chain—that determine the O-antigenic specificity (serogroup B) of the bacterium (Micoli et al., 2018). Biologically, this polysaccharide acts as a protective shield against the host's innate immune system, specifically preventing the membrane attack complex of the complement system from reaching the bacterial outer membrane (MacLennan et al., 2014). It also serves as a receptor for various bacteriophages and plays a role in biofilm formation and environmental survival. In clinical medicine, the O-polysaccharide is a major target for vaccine development, particularly glycoconjugate vaccines where the polysaccharide is chemically linked to a carrier protein to enhance T-cell dependent immune responses (Baliban et al., 2017). Therapeutic strategies focusing on this target aim to elicit bactericidal antibodies that promote opsonophagocytosis and neutralize the pathogen during infection (Rondini et al., 2013). Challenges in targeting this molecule include its high structural diversity across different serovars and the necessity of removing the toxic Lipid A component during the manufacturing of polysaccharide-based therapeutics (Micoli et al., 2018).
Induction of opsonophagocytic and bactericidal antibodies
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella Typhimurium O-polysaccharide (O-PS) (O-PS).